NeuroX1
PrivateLast Round
Seed
Jun 4, 2024
Est. Valuation
$5M
Total Funding Raised
$1.96M
Company Overview
NeuroX1 is a biotechnology company that utilizes artificial intelligence and machine learning to identify disease drivers and develop small molecule therapeutics for neurological and neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroX1 Comparables
Compare NeuroX1 with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Verge Genomics | 81% | |
| Exin Therapeutics | 80% | |
| Aqemia | 77% |
NeuroX1 Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 4, 2024 | ||||
| Accelerator | Mar 11, 2024 | ||||
| Seed | Mar 3, 2023 | ||||
| Pre Seed | Dec 31, 2021 |
Key People
Founding team and executive leadership
NeuroX1 Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Techstars | Seed, Accelerator |
| Capital Factory | Seed, Pre Seed |
| Trousdale Ventures | Seed, Pre Seed |
| Vibe Capital | Pre Seed |
| Next Sequence | Accelerator, Seed |
| Drive Capital | Pre Seed, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2023
$500K round led by Drive Capital.
- Dec 31, 2021
$1.34M round led by Drive Capital
NeuroX1 Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NeuroX1's valuation, stock price, and market status.
Is NeuroX1 a public or private company?
NeuroX1 is a private company.
What is the current stock price of NeuroX1?
NeuroX1 is a private company with no public stock price. No recent secondary market data is available.
How much is NeuroX1 worth (valuation)?
Valuation information for NeuroX1 is not publicly available.
Can I buy NeuroX1 stock?
NeuroX1 shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NeuroX1's last funding round?
NeuroX1's most recent funding round was Series C on June 4, 2024.
Who are the main investors in NeuroX1?
Key investors in NeuroX1 include Techstars, Drive Capital.
Will NeuroX1 IPO soon?
No public IPO plans have been announced for NeuroX1.
How can I track NeuroX1 secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NeuroX1's secondary market activity and sign up for updates.